or
forgot password
  • cancer clinical trials in san francisco, CA

  • Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
    USCF School of Medicine
    San Francisco, California 94143
    NEUROBLASTOMA
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    University of California San Francisco Medical Center-Mount Zion
    San Francisco General Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Brain Tumor, Central Nervous System Tumor
    Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms
    University of California
    San Francisco, California 94108
    Aneurysms, Arteriovenous Malformations
    N2001-02: I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Neuroblastoma
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Pacific Hematology Oncology
    San Francisco, California 94115
    Non-Small Cell Lung Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Kaiser Permanente-San Francisco

    Trial Locations
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    San Francisco General Hospital Medical Center
    San Francisco, California 94110
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center

    Trial Locations
    UCSF Helen Diller Family Comprehensive Cancer Center
    California Pacific Medical Center - California Campus
    San Francisco General Hospital Medical Center
    Head and Neck Cancer
    Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Brain and Central Nervous System Tumors
    Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Cervical Cancer, Precancerous Condition
    Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
    Pacific Hematology Oncology Associates
    San Francisco, California 94115
    Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC)
    Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer
    131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Neuroblastoma
    GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
    UCSF Department of Neurosurgery
    San Francisco, California 94143
    Brain and Central Nervous System Tumors
    Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Neuroblastoma
    Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Pain, Perioperative/Postoperative Complications, Sarcoma
    Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy in Treating Women With Invasive Breast Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer
    Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer
    GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Prostate Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    California Pacific Medical Center - California Campus
    San Francisco, California 94118
    Prostate Cancer
    Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Lymphoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    Kaiser Permanente-San Francisco
    San Francisco General Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Head and Neck Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    Kaiser Permanente Medical Center - San Francisco Geary Campus

    Trial Locations
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    California Pacific Medical Center - California Campus
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    San Francisco General Hospital
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center

    Trial Locations
    UCSF Helen Diller Family Comprehensive Cancer Center
    California Pacific Medical Center - California Campus
    Prostate Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
    University of California San Francisco
    San Francisco, California 941104206
    Ovarian Cancer, Merkel Cell Carcinoma, SCLC
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Leukemia
    A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
    University of California, San Francisco Comprehensive Cancer Center
    San Francisco, California 94143-1770
    Non-small Cell Lung Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Brain and Central Nervous System Tumors
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    San Francisco, California 94115
    Breast Cancer